In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting

Nuclear Medicine and Biology

Volumn 26, Issue 6, 1999, Pages 687-693

  Chen, Jianqing ^a   Giblin, Michael F ^a   Wang, Nannan ^a   Jurisson, Silvia S ^a   Quinn, Thomas P ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

MSH; 99mTc CGCG NDPMSH; Biodistribution; MAG2; Melanoma

Indexed keywords

ALPHA INTERMEDIN; PEPTIDE; TECHNETIUM 99M; TETRAPEPTIDE; ALPHA MSH (5 10), PHE(7); ALPHA-MSH (5-10), PHE(7)-; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; INTERMEDIN; MSH, 4 NLE 7 PHE ALPHA; MSH, 4-NLE-7-PHE-ALPHA-; RADIOPHARMACEUTICAL AGENT; RHENIUM; TECHNETIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TARGETING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MELANOMA; MOUSE; NONHUMAN; ANIMAL; C57BL MOUSE; EXPERIMENTAL MELANOMA; KINETICS; SCINTISCANNING; SYNTHESIS; TISSUE DISTRIBUTION;

ALPHA-MSH; ANIMALS; FEMALE; INDICATORS AND REAGENTS; KINETICS; MELANOCYTE-STIMULATING HORMONES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; RADIOPHARMACEUTICALS; RHENIUM; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 0032590041     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00032-3     Document Type: Article

References (34)

1. Al-Obeidi F., Castrucci A.M.L., Hadley M.E., Hruby V.J. Potent and prolonged acting cyclic lactam analogs of α-melanotropin Design based on molecular dynamics . J. Med. Chem. 32:1989;2555-2561.
2. 111In-DPTA-labeled analogs of alpha-melanocyte-stimulating hormone for melanoma targeting receptor binding in vitro and in vivo . Int. J. Cancer. 58:1994;749-755.
3. Bard D.R., Knight C.G., Page-Thomas D.P. A chelating derivative of α-melanocyte stimulating hormone as a potential imaging agent for malignant melanoma. Br. J. Cancer. 62:1990;919-922.
4. Brown M., Rivier J., Vale W. Bombesin Potent effects on thermoregulation in the rat . Science. 196:1977;998-1000.
5. Chen J.Q., Strand S-E, Tennvall J., Lindgren L., Hindorf C., Sjogren H-O. Extracorporeal immunoadsorption compared to avidin chase Enhancement of tumor-to-normal tissue ratio for biotinylated rhenium-188-chimeric BR96 . J. Nucl. Med. 38:1997;895-901.
6. Cody W.L., Mahoney M., Knittle J.J., Hruby V.J., Castrucci A.M., Hadley M.E. Cyclic melanotropin 7-D-phenylalanine analogs of active-site sequence. J. Med. Chem. 28:1985;583-588.
7. Cone R.D., Mountjoy K.G., Robbins L.S., Nadeau J.H., Johnson K.R., Roselli-Rehfuss L., Mortrud M.T. Cloning and functional characterization of a family of receptors for the melanotropin peptides. Ann. N.Y. Acad. Sci. 680:1993;342-363.
8. Fritzberg A.R., Abrams P.G., Beaumier P.L., Kasina S., Morgan A.C., Rao T.N., Reno J.M., Sanderson J.A., Srinivasan A., Wilbur D.S., Vanderheyden J.L. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA. 85:1988;4025-4029.
9. Fritzberg A.R., Berninger R.W., Hadley S.W., Wester D.W. Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer. Pharm. Res. 5:1988;325-334.
10. Garg P.K., Alston K.L., Welsh P.C., Zalutsky M.R. Enhanced binding and inertness to dehalogenation of α-melanotropin peptides labeled using N-succinimidyl 3-iodobenzoate. Bioconjugate Chem. 7:1996;233-239.
11. George A. J., Jamar F., Tai M-S., Heelan B. T., Adams G. P., McCartney J. E., Houston L. L., Weiner L. M., Oppermann H. and Peters A. M. (1995) Radiometal labeling of recombination proteins by a genetically engineered minimal chelation site: Technetium-99m combination by single-chain Fv antibody fusion proteins though a C-terminal cysteinyl peptide. Proc. Natl. Acad. Sci. USA 92, 8385-8362.
12. Giblin M.F., Jurisson S.S., Quinn T.P. Synthesis and characterization of rhenium-complexed α-melanotropin analogs. Bioconjugate Chem. 8:1997;347-353.
13. Giblin M.F., Wang N., Hoffman T.J., Jurisson S.S., Quinn T.P. Design and characterization of alpha-melanotropin peptide analogs cyclized though rhenium and technetium metal coordination. Proc. Natl. Acad. Sci. USA. 95:1998;12814-12818.
14. Goldrosen M.B., Biddle W.C., Pancook J., Bakshi S., Vanderheyden J.L., Fritzberg A.R., Morgan A.C., Foon K.A. Biodistribution, pharmacokinetics, and imaging studies with Re-186-labeled NR-LU-10 whole antibody in LS 174T colonic tumor bearing mice. Cancer Res. 50:1990;7973-7978.
15. Griffiths G.L., Goldenberg D.M., Knapp F.F., Callahan A.P., Chang C-H, Hansen H.J. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radiotherapy Labeling and animal biodistribution studies . Cancer Res. 51:1991;4594-4602.
16. 2, on human melanotropin receptors. J. Med. Chem. 40:1997;1738-1748.
17. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
18. Hruby V.J., Sharma S.D., Toth K., Jaw J.Y., Al-Obeidi F.A., Sawyer T.K., Hadley M.E. Design, synthesis, and conformation of superpotent and prolonged acting melanotropin. Ann. N.Y. Acad. Sci. 680:1993;51-63.
19. Kasina S., Rao T.N., Srinivasan A., Sanderson J.A., Fitzner J.N., Reno J.M., Beaumier P.L., Fritzberg A.R. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent. J. Nucl. Med. 32:1991;1445-1451.
20. 131I-labeled antibody in multicell spheroids. Int. J. Radiat. Oncol. Biol. Phys. 24:1992;127-132.
21. 99mTc-chelator-peptide conjugates . Bioconjugate Chem. 7:1996;196-202.
22. Mather S. J., Ellison D. and Bard D. S. (1995) Technetium-99m labelled hybrid receptor-binding peptide. In: Technetium and Rhenium in Chemistry and Nuclear Medicine 4, pp. 491-497. SG Editoriali, Padova, Italy.
23. Morandini R., Vargha H.S., Libert A., Loir B., Botyanszki J., Medzihradszky K., Ghanem G. Receptor-mediated cytotoxicity of α-MSH fragments containing melphalan in a human melanoma cell line. Int. J. Cancer. 56:1994;129-133.
24. Plantinga L.C., Verhaagen J., Edwards P.M., Hali M., Brakkee J.H., Gispen W.H. Pharmacological evidence for the involvement of endogenous α-MSH-like peptides in peripheral nerve regeneration. Peptides. 16:1995;319-324.
25. 186Re-labeling of monoclonal antibodies. Cancer. 73:(suppl.):1994;769-773.
26. Sahm U.G., Oliver G.W.J., Branch S.K., Moss S.H., Pouton C.W. Synthesis and biological evaluation of α-MSH analogs substituted with alanine. Peptides. 15:1994;1297-1302.
27. Saywer T.K., Sanfilippo P.J., Hruby V.J., Engel M.H., Heward C.B., Burnett J.B., Hadley M.E. 4-Norleucine, 7-D-phenylalanine-α-melanocyte-stimulating hormone A highly potent α-melanotropin with ultralong biological activity . Proc. Natl. Acad. Sci. USA. 77:1980;5754-5758.
28. Sharma S.D., Jiang J., Hadley M.E., Bentley D.L., Hruby V.J. Melanotropin peptide-conjugated beads for microscopic visualization and characterization of melanoma melanotropin receptors. Proc. Natl. Acad. Sci. USA. 93:1996;13715-13720.
29. Siegrist W., Oestreicher M., Stutz S., Girard J., Eberle A.E. Radio-receptor assay for α-MSH using mouse B16 melanoma cells. J. Recept. Res. 8:1988;323-343.
30. Siegrist W., Solca F., Stutz S., Giuffre L., Carrel S., Girard J., Eberle A.N. Characterization of receptors for α-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 49:1989;6352-6358.
31. 7]-α-MSH, an α-melanocyte stimulating hormone analog. Nucl. Med. Biol. 24:1997;171-178.
32. Vallabhajosula S., Moyer B.R., Lister-James J., McBride B.J., Lipszyc H., Lee H., Bastidas D., Dean R.T. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J. Nucl. Med. 37:1996;1016-1022.
33. 99mTc-labelled agents. Nucl. Med. Biol. 22:1995;325-338.
34. Wraight E.P., Bard D.R., Maughan C.G., Knight C.G., Page-Thomas D.P. The use of a chelating derivative of alpha-melanocyte stimulating hormone for the clinical imaging of malignant melanoma. Br. J. Radiol. 65:1992;112-118.